This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ciaraldi, T. P. Articles by Henry, R. R. Search for Related Content PubMed PubMed Citation Articles by Ciaraldi, T. P. Articles by Henry, R. R. Related Collections Diabetes and Insulin

Skeletal Muscle GLUT1 Transporter Protein Expression and Basal Leg Glucose Uptake Are Reduced in Type 2 Diabetes

Veterans Affairs San Diego HealthCare System, San Diego, California 92161; and Department of Medicine, University of California-San Diego, La Jolla, California 92093

Address all correspondence and requests for reprints to: Dr. Robert R. Henry, Veterans Affairs San Diego HealthCare System (111G), 3350 La Jolla Village Drive, San Diego, California 92161. E-mail: rrhenry{at}vapop.ucsd.edu.

To investigate the role of skeletal muscle tissue expression of the glucose transporter protein GLUT1 in mediating glucose disposal in the basal (fasting) state, skeletal muscle biopsies (vastus lateralis) were obtained from lean and obese nondiabetics and type 2 diabetic subjects. Basal and insulin-stimulated glucose uptakes were measured. Basal whole body glucose uptake was measured using isotope dilution, and arteriovenous catheterization limb balance was used to determine leg muscle glucose uptake. Basal (noninsulin-stimulated) whole body glucose uptake was higher in the type 2 group compared with the controls (2.26 ± 0.17 vs. 1.83 ± 0.15 mg/kg·min; P < 0.05). However, basal leg muscle glucose uptake was reduced in diabetic subjects (1.53 ± 0.56 vs. 3.89 ± 0.83 mg/100 ml·min; P < 0.025) despite basal hyperglycemia (230 ± 13 vs. 94 ± 2 mg/dl; P < 0.0005). Skeletal muscle GLUT1 protein expression was lower in the type 2 subjects (57 ± 12 vs. 91 ± 11 arbitrary units/10 µg protein; P < 0.05), although GLUT1 mRNA levels did not differ. In summary, 1) skeletal muscle tissue GLUT1 protein expression is reduced in type 2 diabetes and could contribute to impaired basal leg glucose uptake; and 2) elevated rates of basal whole body glucose uptake in type 2 diabetes are due to uptake in tissues other than skeletal muscle.

This article has been cited by other articles:

				R. Jani, M. Molina, M. Matsuda, B. Balas, A. Chavez, R. A. DeFronzo, and M. Abdul-Ghani Decreased Non-Insulin-Dependent Glucose Clearance Contributes to the Rise in Fasting Plasma Glucose in the Nondiabetic Range Diabetes Care, February 1, 2008; 31(2): 311 - 315. [Abstract] [Full Text] [PDF]

				H. E. Silber, P. M. Jauslin, N. Frey, R. Gieschke, U. S. H. Simonsson, and M. O. Karlsson An Integrated Model for Glucose and Insulin Regulation in Healthy Volunteers and Type 2 Diabetic Patients Following Intravenous Glucose Provocations J. Clin. Pharmacol., September 1, 2007; 47(9): 1159 - 1171. [Abstract] [Full Text] [PDF]

				L. Gnudi, S. M. Thomas, and G. Viberti Mechanical Forces in Diabetic Kidney Disease: A Trigger for Impaired Glucose Metabolism J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2226 - 2232. [Abstract] [Full Text] [PDF]